Dr. Sandler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1812 10th Ave E
Seattle, WA 98102Phone+1 206-328-6558
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1994 - 1996
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1990 - 1994- Icahn School of Medicine at Mount SinaiClass of 1990
Certifications & Licensure
CA State Medical License 1994 - Present
WA State Medical License 1997 - 2026
Clinical Trials
- Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer Start of enrollment: 2000 Oct 01
- Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer
- Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer Start of enrollment: 2011 Dec 01
Press Mentions
Kiadis Announces First Patient Enrolled in Clinical Study Conducted at the Ohio State University in R/R AML with Off-the-Shelf K-NK Cells from Universal Donors as Part of Its K-nK003 ProgramJune 25th, 2020
Kiadis Pharma Announces FDA Clearance of Clinical Study by the Ohio State University in R/R AML with Off-the-Shelf NK Cells from Universal DonorsFebruary 27th, 2020
Kiadis Pharma Appoints Dr. Andrew Sandler as Chief Medical OfficerSeptember 29th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
